In a mouse model of PDAC, blockade of galectin-9 function could effectively retard tumor progression and prolonged survival by inducing maturation and expansion of macrophages and dendritic cells, and modulating the immune response of NK and tumor-associated CD8+ T cells (141–, 143). The gene discussed is LGALS9; the disease is neoplasm.